Pancreatic Cancer Research

ResearcherThomas Jefferson UniversityNo recent work listed

Daniel Monti

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8557-3953; OpenAlex author ID A5050756470. Sources: ClinicalTrials.gov.

Their work

Papers
1
Trials
2 (principal investigator on 2)
Grants
0
Labs led
0
Collaborators
3
Papers, trials and grants by year

2009: 1 trial · 2010: none · 2011: 1 trial · 2012: 1 paper

Papers 1

  1. Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer. Co-author DOI 10.1371/journal.pone.0029794↗

Trials 2

  1. Assessing the Efficacy and Safety of IV Vitamin C in Combination With Standard Chemotherapy for Pancreatic Ca Principal investigator NCT01555489↗
  2. Intravenous Vitamin C in Combination With Standard Chemotherapy for Pancreatic Cancer Principal investigator NCT00954525↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Edith Peterson Mitchell · 1 shared paper, 1 shared trial, 2011–2012 · strength 0.11
  2. Mark N. Levine · 1 shared paper, 2012 · strength 0.03
  3. Charles J. Yeo · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.